New User? Click here to register

HER2-Targeted Therapies: Beyond Trastuzumab

Text generated by AI based on an exclusive interview, revised and reviewed by

Dr Jean-Philippe MINART, Cannes, France

February 6, 2024

Hassan GHAZAL, MD, Dubai UAE, Medical Oncologist and Hematologist, Dubai, UAE

Hassan GHAZAL
MD, Dubai UAE, Medical Oncologist and Hematologist, Dubai, UAE

Screening High-Risk Women: BRCA, TP53 and Others
Miguel Braga
FDG Pet CTscan for treatment response evaluation.
Eric ZERBIB
Second look study after PET-CT. How to target?
Willy VANGU
Quels ont été les principaux drivers des avancées dans le cancer du sein ?
Jean-Philippe SPANO

Chairman of Oncology department , University hospital Pitié-Salpétrière, Paris, France
Quelles sont les spécialités concernées par le BCU et pourquoi assister à ce congrès ?
Luc Rotenberg
Neuilly sur Seine, France
Expert Opinions Dubai 2022
Breast Cancer Update

Leave a Comment cancel

You must be logged in to post a comment.